Profile of:
Ping Zhu
Professor Ping Zhu, renowned expert in the field of Rheumatology & Immunology, is the Chief Physician of Xijing Hospital of Fourth Military Medical University, principal investigator of National Facility for Translational Medicine, Vice-Chairman of Autoimmune Branch of Chinese Society for Immunology(CSI), President of Rheumatology and Molecular Immunology Branch of National Association of Health Industry and Enterprise Management(NAHIEM), Honorary Chairman of the Rheumatology and Immunology Committee of the China Medical Women’s Association(CMWA), Vice-Chairman of the 9th Committee of the Rheumatology Branch of the Chinese Medical Association(CMA), Vice-President of the 1st and 2nd Committee of the Rheumatology and Immunology Branch of the Chinese Medical Doctor Association(CMDA), chairman of Rheumatology and Immunology Branch of Shannxi Medical Doctor Association. Professor Ping Zhu has a long-standing interest in the medical education, health care, and scientific research in the field of Rheumatology and Immunology for over 40 years. She was awarded the Military outstanding Young and Middle-aged Technical Expert, Chinese Doctor Award and Special Government Allowances of the State Council. She has obtained a lot of national grants, including National Basic Research Program of China (973 Program)，National Hi-tech Research and Development Program of China (863 Program), and Key Program of National Natural Science Fund, etc. As the first or corresponding author she has published 119 SCI papers, including 8 top international journal papers published in Science, Cell metab, CMI, Blood, etc. with the IF≧20, total citation of 3654 times, and 1 ESI top 11‰ hot paper and 4 top 1% highly cited papers. She won the second prize of National Science and Technology Progress twice, first prize of Provincial and Ministerial 7 times. And she was granted 4 international invention patents and 14 national invention patents. As an editor-in-chief she has authored 4 books, and trained 103 Master/PhD students.
Full name: Ping Zhu
Current country: China
Membership level: Full
Type of membership: Member
Number of publications: 57
Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity (2023)
https://pubmed.ncbi.nlm.nih.gov/36927018/
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial (2023)
https://pubmed.ncbi.nlm.nih.gov/36717539/
Immunological and metabolic characteristics of the Omicron variants infection (2023)
https://pubmed.ncbi.nlm.nih.gov/36681668/
Deep-learning based quantification model for hip bone marrow edema and synovitis in patients with Spondyloarthritis based on Magnetic Resonance Images (2023)
https://pubmed.ncbi.nlm.nih.gov/36935744/
Combination Immunotherapy of Glioblastoma with Dendritic Cell Cancer Vaccines, Anti-PD-1 and Poly I:C (2023)
https://pubmed.ncbi.nlm.nih.gov/37440907/
Post-translationally modified neoantigens: Promising targets for diagnostic strategy of autoimmune diseases (2023)
https://pubmed.ncbi.nlm.nih.gov/37592373/
CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis (2022)
https://pubmed.ncbi.nlm.nih.gov/36424379/
SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner (2022)
https://pubmed.ncbi.nlm.nih.gov/35343395/
TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collageninduced arthritis mouse models (2022)
https://pubmed.ncbi.nlm.nih.gov/35115492/
T cell abnormalities in systemic sclerosis (2022)
https://pubmed.ncbi.nlm.nih.gov/36031049/
Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model. (2022)
https://pubmed.ncbi.nlm.nih.gov/36302319/
Th1-Like Treg Cells Are Increased But Deficient in Function in Rheumatoid Arthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35603149/
Follow-up Contrast-Enhanced Ultrasonography of the Carotid Artery in Patients With Takayasu Arteritis: A Retrospective Study (2022)
https://pubmed.ncbi.nlm.nih.gov/35705241/
ACPA-CD147 axis in the NLRP3 inflammasome of RA macrophages (2022)
https://pubmed.ncbi.nlm.nih.gov/35729222/
TNF-α inhibitor ameliorates immune-related arthritis and pneumonitis in humanized mice (2022)
https://pubmed.ncbi.nlm.nih.gov/36016934/
The Establishment and Validation of Reference Intervals for Plasma Pentraxin-3 in Healthy Volunteers and Patients with Takayasu’s Arteritis (2022)
https://pubmed.ncbi.nlm.nih.gov/36279941/
Case report: Kimura’s disease with minimal degenerative glomerulopathy without eosinophil infiltration responds to mycophenolate mofetil treatment (2022)
https://pubmed.ncbi.nlm.nih.gov/36698834/
CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 and its variants delta, alpha, beta, and gamma. (2021)
https://pubmed.ncbi.nlm.nih.gov/34564690/
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial (2021)
https://pubmed.ncbi.nlm.nih.gov/34001849/
Di-methylation of CD147-K234 Promotes the Progression of NSCLC by Enhancing Lactate Export (2021)
https://pubmed.ncbi.nlm.nih.gov/33406400/
CD98-induced CD147 signaling stabilizes the Foxp3 protein to maintain tissue homeostasis (2021)
https://pubmed.ncbi.nlm.nih.gov/34759371/
The impact of cell-type and context-dependent regulatory variants on human immune traints (2021)
https://pubmed.ncbi.nlm.nih.gov/33926512/
Osteonecrosis in systemic lupus erythematosus: systematic insight from the epidemiology, pathogenesis, diagnosis and management (2021)
https://pubmed.ncbi.nlm.nih.gov/34793961/
Regulatory T Cell Heterogeneity and Therapy in Autoimmune Diseases (2021)
https://pubmed.ncbi.nlm.nih.gov/33197573/
Dysregulation of Innate Lymphoid Cells in Patients with Active Rheumatoid Arthritis and Mice with Collagen-Induced Arthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33688303/
Alignment of single-cell RNA-seq samples without Proof Onlyovercorrection using kernel density matching (2021)
https://pubmed.ncbi.nlm.nih.gov/33741686/
A comprehensive assessment of hip damage in ankylosing spondylitis, especially early features (2021)
https://pubmed.ncbi.nlm.nih.gov/33841450/
Iguratimod reduces B-cell secretion of immunoglobulin to play a protective role in interstitial diseases (2021)
https://pubmed.ncbi.nlm.nih.gov/33892300/
Effects of illness perceptions on health-related quality of life in patients with rheumatoid arthritis in China (2021)
https://pubmed.ncbi.nlm.nih.gov/33879176/
Testing if Micro-CT is capable of quantitating the extent of Proteoglycan-Aggrecan induced Axial Spondyloarthritis in mice (2021)
https://pubmed.ncbi.nlm.nih.gov/34290703/
Automatic quantification and grading of hip bone marrow edema in ankylosing spondylitis based on deep learning Modern Rheumatology (2021)
https://pubmed.ncbi.nlm.nih.gov/34918143/
The Clinical and MRI Effect of TNF-α Inhibitors in Spondyloarthritis Patients With Hip Involvement: A Real-World Observational Clinical Study (2021)
https://pubmed.ncbi.nlm.nih.gov/34659233/
Deep learning-based artificial intelligence system for automatic assessment of glomerular pathological findings in lupus nephritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34829330/
Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer (2021)
https://pubmed.ncbi.nlm.nih.gov/35069521/
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells (2020)
https://pubmed.ncbi.nlm.nih.gov/33277466/
ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome. (2020)
https://pubmed.ncbi.nlm.nih.gov/30911117/
Nonclinical safety, tolerance and pharmacodynamics evaluation for meplazumab treating chloroquine-resistant Plasmodium falciparum (2020)
https://pubmed.ncbi.nlm.nih.gov/33088688/
Epithelial Cell Adhesion Molecule in Primary Sjögren’s Syndrome Patients: Characterization and Evaluation of a Potential Biomarker (2020)
https://pubmed.ncbi.nlm.nih.gov/31886299/
The risk of circulating angiogenic T cells and subsets in patients with systemic sclerosis (2020)
https://pubmed.ncbi.nlm.nih.gov/32066116/
IPAF should receive early treatment for sharing similar clinical characteristics as CTD-ILD: a report from 273 Chinese patients (2020)
https://pubmed.ncbi.nlm.nih.gov/32447599/
Regulatory T Cell Heterogeneity and Therapy in Autoimmune Diseases (2020)
https://pubmed.ncbi.nlm.nih.gov/33197573/
Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu’s arteritis patients (2020)
https://pubmed.ncbi.nlm.nih.gov/32567005/
A cross-sectional survey of knowledge, attitude and practice associated with COVID-19 among undergraduate students in China (2020)
https://pubmed.ncbi.nlm.nih.gov/32847554/
CD147 expressed on memory CD4+ T cells limits Th17 responses in patients with rheumatoid arthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33193313/
CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/ATR/p53 and affects prognosis in pancreatic cancer (2020)
https://pubmed.ncbi.nlm.nih.gov/32456796/
Application and preliminary validation of the hip inflammation MRI scoring system (HIMRISS) in spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30548414/
TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/30548414/
Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis (2018)
https://pubmed.ncbi.nlm.nih.gov/30548414/
TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis monocytes (2018)
https://pubmed.ncbi.nlm.nih.gov/30548414/
Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum. (2018)
https://pubmed.ncbi.nlm.nih.gov/29352039/
Functional defects in CD4 + CD25 high FoxP3 + regulatory cells in ankylosing spondylitis (2016)
https://pubmed.ncbi.nlm.nih.gov/27901054/
Increased expression of human leucocyte antigen class I free heavy chains on monocytes of patients with spondyloarthritis and cells transfected with HLA-B27 (2015)
https://pubmed.ncbi.nlm.nih.gov/27901054/
Performance of ultrasound to monitor Achilles enthesitis in patients with ankylosing spondylitis during TNF-a antagonist therapy (2015)
https://pubmed.ncbi.nlm.nih.gov/27901054/
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial (2014)
https://pubmed.ncbi.nlm.nih.gov/27901054/
Efficacy and safety of celecoxib in chinese patients with ankylosing spondylitis: a 6-week randomized, double-blinded study with 6-week open-label extension treatment (2014)
https://pubmed.ncbi.nlm.nih.gov/27901054/
Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy (2013)
https://pubmed.ncbi.nlm.nih.gov/27901054/
Interferon-γ contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies (2012)
https://pubmed.ncbi.nlm.nih.gov/27901054/
